269
Views
28
CrossRef citations to date
0
Altmetric
Original

The Boston Ocular Surface Prosthesis as a Novel Drug Delivery System for Bevacizumab

, , &
Pages 149-155 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lianghui Zhao, Jike Song, Yongle Du, Cong Ren, Bin Guo & Hongsheng Bi. (2023) Therapeutic applications of contact lens-based drug delivery systems in ophthalmic diseases. Drug Delivery 30:1.
Read now
Michael L Rolfsen, Nicholas E Frisard, Ethan M Stern, Timothy P Foster, Partha S Bhattacharjee, Harris E McFerrin Jr, Christian Clement, Paulo C Rodriguez, Walter J Lukiw, Donald R Bergsma, Augusto C Ochoa & James M Hill. (2013) Corneal neovascularization: a review of the molecular biology and current therapies. Expert Review of Ophthalmology 8:2, pages 167-189.
Read now

Articles from other publishers (26)

Daddi Fadel & Melissa Barnett. 2024. Contact Lens Practice. Contact Lens Practice 290 302.e4 .
Stephen J. Vincent. 2024. Contact Lens Practice. Contact Lens Practice 175 184.e3 .
Bita Asghari & Daniel C. Brocks. (2023) Early Postoperative Therapeutic Scleral Lens Intervention for Penetrating Keratoplasty Complications in Atopic Keratoconjunctivitis. Eye & Contact Lens: Science & Clinical Practice 49:6, pages 254-257.
Crossref
Behnam Abdi, Mohammad Mofidfar, Fatemeh Hassanpour, Emel Kirbas Cilingir, Sepideh K. Kalajahi, Paria H. Milani, Mahsa Ghanbarzadeh, Daddi Fadel, Melissa Barnett, Christopher N. Ta, Roger M. Leblanc, Anuj Chauhan & Farhang Abbasi. (2023) Therapeutic contact lenses for the treatment of corneal and ocular surface diseases: Advances in extended and targeted drug delivery. International Journal of Pharmaceutics 638, pages 122740.
Crossref
Nguyễn Thị Thanh Nhàn, Daniel E. Maidana & Kaori H. Yamada. (2023) Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides. Cells 12:7, pages 1071.
Crossref
Jonghwa Kim, Himangsu Mondal, Rujun Jin, Hyeon Jeong Yoon, Ho-Joong Kim, Jun-Pil Jee & Kyung Chul Yoon. (2023) Cellulose Acetate Phthalate-Based pH-Responsive Cyclosporine A-Loaded Contact Lens for the Treatment of Dry Eye. International Journal of Molecular Sciences 24:3, pages 2361.
Crossref
Maria K. Walker, Muriel M. Schornack & Stephen J. Vincent. (2021) Anatomical and physiological considerations in scleral lens wear: Eyelids and tear film. Contact Lens and Anterior Eye 44:5, pages 101407.
Crossref
Emily Witsberger & Muriel Schornack. (2021) Scleral Lens Use in Neurotrophic Keratopathy: A Review of Current Concepts and Practice. Eye & Contact Lens: Science & Clinical Practice 47:3, pages 144-148.
Crossref
Aliasgar Shahiwala. 2021. Applications of Polymers in Drug Delivery. Applications of Polymers in Drug Delivery 355 392 .
Gary D. NovackMelissa Barnett. (2020) Ocular Drug Delivery Systems Using Contact Lenses. Journal of Ocular Pharmacology and Therapeutics 36:8, pages 595-601.
Crossref
Giuseppe Giannaccare, Marco Pellegrini, Cristina Bovone, Rossella Spena, Carlotta Senni, Vincenzo Scorcia & Massimo Busin. (2020) Anti-VEGF Treatment in Corneal Diseases. Current Drug Targets 21:12, pages 1159-1180.
Crossref
Debby Chang, Kinam Park & Amin Famili. (2019) Hydrogels for sustained delivery of biologics to the back of the eye. Drug Discovery Today 24:8, pages 1470-1482.
Crossref
Karolina Fedotova, Valeriy R. Grabovetsky, Sergey A. Novikov & Maggie Ezugbaya. (2019) Miniscleral lenses in the treatment of patients with dry eye syndrome (first own experience). Ophthalmology Reports 12:1, pages 5-12.
Crossref
Daddi Fadel & Elise Kramer. (2019) Potential contraindications to scleral lens wear. Contact Lens and Anterior Eye 42:1, pages 92-103.
Crossref
Jia Yin & Deborah S. Jacobs. (2019) Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization. The Ocular Surface 17:1, pages 134-141.
Crossref
Hualei Zhai, Paulo J.M. Bispo, Hidenaga Kobashi, Deborah S. Jacobs, Michael S. Gilmore & Joseph B. Ciolino. (2018) Resolution of fluoroquinolone-resistant Escherichia coli keratitis with a PROSE device for enhanced targeted antibiotic delivery. American Journal of Ophthalmology Case Reports 12, pages 73-75.
Crossref
Ellen Shorter, Jennifer Harthan, Cherie B. Nau, Amy Nau, Joseph T. Barr, David O. Hodge & Muriel M. Schornack. (2018) Scleral Lenses in the Management of Corneal Irregularity and Ocular Surface Disease. Eye & Contact Lens: Science & Clinical Practice 44:6, pages 372-378.
Crossref
Renaud Laballe, Jonathan Vigne, Eric Denion, Florian Lemaitre, Didier Goux & Pierre-Jean Pisella. (2016) Preclinical assessment of scleral lens as a reservoir-based ocular therapeutic system. Contact Lens and Anterior Eye 39:5, pages 394-396.
Crossref
Muriel M. Schornack. (2015) Scleral Lenses. Eye & Contact Lens: Science & Clinical Practice 41:1, pages 3-11.
Crossref
Deborah S. Jacobs & Joshua S. Agranat. 2014. Advances in Medical and Surgical Cornea. Advances in Medical and Surgical Cornea 57 69 .
Bjoern Bachmann, Rod S. Taylor & Claus Cursiefen. (2011) The association between corneal neovascularization and visual acuity: a systematic review. Acta Ophthalmologica 91:1, pages 12-19.
Crossref
Anna Cressey, Deborah S. Jacobs & Karen G. Carrasquillo. (2012) Management of Vascularized Limbal Keratitis With Prosthetic Replacement of the Ocular Surface System. Eye & Contact Lens: Science & Clinical Practice 38:2, pages 137-140.
Crossref
J Menzel-Severing. (2011) Emerging techniques to treat corneal neovascularisation. Eye 26:1, pages 2-12.
Crossref
Anne M. Keating & Deborah S. Jacobs. (2011) Anti-VEGF Treatment of Corneal Neovascularization. The Ocular Surface 9:4, pages 227-238.
Crossref
Omar M. Kirat & Hassan A. Al-Dhibi. (2010) Regression of aggressive corneal vascularization after photodynamic therapy, subconjunctival Avastin injections and topical cyclosporin-A 1% drops: A case report. Saudi Journal of Ophthalmology 24:4, pages 151-154.
Crossref
Uday B Kompella, Rajendra S Kadam & Vincent HL Lee. (2010) Recent advances in ophthalmic drug delivery. Therapeutic Delivery 1:3, pages 435-456.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.